by Jordana Choucair | Apr 20, 2022 | Public Health/Prevention
The CDC said that a new omicron subvariant is taking off in the United States and now makes up roughly 1 in 5 new COVID-19 cases. State health officials in New York estimate that the new variant, an offshoot of the dominant BA.2 version, is more transmissible than the...
by Jordana Choucair | Apr 19, 2022 | Access & Coverage
The Supreme Court dismissed cases disputing the Trump administration’s approval of Medicaid work requirements in Arkansas and New Hampshire. The justices on Monday agreed the cases are now moot and sent them back to the trial court with instructions to wipe the...
by Jordana Choucair | Apr 19, 2022 | Opioid/Substance Use Disorders
West Virginia announced it finalized a settlement with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. over the drugmaker’s role in perpetuating the state’s opioid crisis. According to Attorney General Patrick Morrisey, the $99 million settlement is...
by Jordana Choucair | Apr 19, 2022 | Payers
A new study published in JAMA Internal Medicine found that the prices that private insurers agree to pay hospitals for cancer drugs are often at least double what the hospital paid to acquire the drugs. According to the study, the median price markups of 25...
by Jordana Choucair | Apr 19, 2022 | Payers
The CMS released the proposed Hospital Inpatient Prospective Payment System rule, representing a 3.2 percent increase in FY 2023 payments. The agency also wants to add health equity measures to the hospital inpatient quality reporting program, including one that...
Recent Comments